ArticleAnnals of translational medicine2017

Comparative effectiveness and safety of empagliflozin on cardiovascular mortality and morbidity in adults with type 2 diabetes.

Wilbert S Aronow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.